Lipe & Dalton’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-123,771
Closed -$3.23M 88
2017
Q2
$3.23M Buy
123,771
+5,467
+5% +$141K 2.09% 26
2017
Q1
$3.04M Buy
118,304
+220
+0.2% +$5.63K 2.2% 22
2016
Q4
$2.85M Buy
+118,084
New +$2.86M 2.03% 24
2014
Q4
Sell
-134,764
Closed -$3.81M 70
2014
Q3
$3.81M Buy
134,764
+1,532
+1% +$47K 2.49% 23
2014
Q2
$4.3M Sell
133,232
-38,192
-22% -$1.2M 2.7% 22
2014
Q1
$5.31M Buy
171,424
+12,913
+8% +$388K 3.55% 7
2013
Q4
$4.52M Buy
+158,511
New +$5.12M 3.09% 16

Other funds holding RYN

Lipe & Dalton's RYN Position: Q3 2017 in Review

Lipe & Dalton sold out of Rayonier (RYN) in Q3 2017, closing a stake of 123,771 shares — an estimated $3.23M sold.

Lipe & Dalton first reported a position in RYN in Q4 2013 and held it in 7 quarters. The position peaked at $5.31M in Q1 2014. 286 funds tracked by Wall St. Rank hold RYN as of Q3 2017.

  • Lipe & Dalton reported no remaining Rayonier position as of Q3 2017 after selling out during the quarter.
  • Lipe & Dalton sold 123,771 Rayonier shares in Q3 2017, an estimated $3.23M.
  • Lipe & Dalton first reported a position in Rayonier in Q4 2013 and held it in 7 quarters.
  • Lipe & Dalton's Rayonier position peaked at $5.31M in Q1 2014.
  • 286 funds tracked by Wall St. Rank held Rayonier as of Q3 2017.

Based on Lipe & Dalton's 13F filing for Q3 2017, filed 3 Nov 2017.